UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025

Introduction

The UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025 is an advanced multidisciplinary educational program designed to provide a broad and clinically practical update across malignant hematology, solid tumor oncology, supportive cancer care, and hematopoietic transplantation. Developed by UW Medicine, this intensive review course delivers a comprehensive synthesis of evolving treatment standards, emerging therapeutics, modern clinical guidelines, and evidence-driven oncology management strategies.

Held October 6–10, 2025 in Seattle, the program brings together expert faculty in hematology and oncology to review current approaches to leukemias, lymphomas, multiple myeloma, breast cancer, thoracic malignancies, gastrointestinal cancers, genitourinary oncology, gynecologic malignancies, immunotherapy, thrombosis management, transfusion medicine, and hematopoietic cell transplantation.

Designed for specialists managing complex oncologic and hematologic disorders, the course emphasizes practical patient care applications, integration of novel therapies, supportive care optimization, and contemporary treatment algorithms relevant to both academic and community oncology practice.

Files Included

The UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025 educational package includes extensive multimedia oncology and hematology learning resources.

Included resources:

• 54 MP4 video lectures
• 54 subtitle files (.vtt)
• 56 downloadable PDF presentations and educational files
• Hematology and oncology review sessions
• Clinical treatment update lectures
• Supportive care and transplantation discussions
• Immunotherapy and pharmacology education
• Case-based oncology learning

Additional highlights:

• Total course size: 27.77 GB
• Five-day intensive review course format
• Expert-led multidisciplinary oncology education
• Self-paced digital learning access

These resources support continuing medical education in hematology, oncology, malignant hematology, solid tumor management, and board-focused cancer medicine review.

Why This Course Is Important

The fields of hematology and oncology continue to evolve rapidly with expanding molecular diagnostics, targeted therapies, immunotherapy strategies, precision oncology, cellular therapies, and increasingly personalized treatment approaches. Clinicians managing hematologic disorders and malignancies must continuously integrate new clinical trial data, evolving guidelines, novel therapeutics, and multidisciplinary treatment strategies into patient care.

At the same time, cancer management has become increasingly complex due to advances in immunotherapy, targeted agents, thrombosis management, supportive care, infectious disease prevention, and transplant medicine. Staying current requires structured educational review from experienced faculty actively engaged in oncology research and clinical practice.

The UW Medicine Comprehensive Hematology & Oncology Review Course 2025 addresses these challenges through a broad, clinically focused curriculum emphasizing practical treatment updates, evidence-informed therapeutic decision-making, and comprehensive cancer care strategies across both hematologic and solid malignancies.

What Participants Will Learn

Participants completing this course will strengthen their expertise in modern hematology and oncology diagnosis, treatment planning, and supportive cancer care.

Learning objectives include:

• Evaluating advances in acute and chronic leukemia management
• Applying updated treatment approaches for lymphomas and multiple myeloma
• Integrating evolving therapies for breast, lung, gastrointestinal, genitourinary, and gynecologic cancers
• Understanding modern immunotherapy and targeted treatment strategies
• Managing complications related to cancer therapy, thrombosis, and infections
• Optimizing supportive oncology and transfusion medicine approaches
• Reviewing contemporary hematopoietic cell transplantation strategies
• Applying updated clinical treatment algorithms in oncology practice
• Interpreting emerging clinical trial data and guideline updates
• Improving multidisciplinary cancer management decision-making

The curriculum integrates malignant hematology, solid tumor oncology, immunotherapy, supportive care, pharmacology, transplantation medicine, and precision oncology into a clinically practical educational experience.

Full Course Topics & Lectures

Malignant Hematology

Acute Leukemias

Chronic Leukemias

Lymphoma Management

Multiple Myeloma Updates

Hematologic Malignancy Treatment Strategies

Solid Tumor Oncology

Breast Cancer Management

Lung Cancer Therapeutics

Gastrointestinal Oncology

Genitourinary Malignancies

Gynecologic Oncology

Contemporary Solid Tumor Treatment Algorithms

Immunotherapy & Targeted Cancer Therapies

Modern Immunotherapy Applications

Targeted Pharmacologic Agents

Precision Oncology Strategies

Emerging Cancer Therapeutics

Clinical Integration of Novel Agents

Supportive Oncology Care

Cancer-Associated Thrombosis

Infectious Disease Management in Oncology

Transfusion Medicine

Symptom Management and Supportive Care

Oncology Complication Management

Hematopoietic Cell Transplantation

Hematopoietic Cell Transplant Strategies

Transplant Patient Evaluation

Post-Transplant Complication Management

Cellular Therapy Developments

Clinical Pharmacology & Treatment Advances

Oncology Pharmacology Updates

Evolving Clinical Trial Data

Therapeutic Algorithm Integration

Guideline-Based Oncology Management

Multidisciplinary Oncology Practice

Comprehensive Cancer Care Planning

Hematology and Oncology Collaboration

Evidence-Informed Clinical Decision-Making

Personalized Oncology Treatment Strategies

Educational Experience & Learning Features

The UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025 combines advanced oncology education with practical multidisciplinary cancer management training.

Educational features include:

• 54 expert-led HD video lectures
• 54 subtitle files for enhanced accessibility
• 56 downloadable PDF educational resources
• Comprehensive hematology and oncology review curriculum
• Clinical guideline and therapeutic updates
• Immunotherapy and targeted therapy education
• Supportive care and transplantation discussions
• Case-based clinical learning
• Multidisciplinary oncology education
• Flexible self-paced digital learning access

The curriculum integrates hematologic malignancies, solid tumor oncology, supportive care, transplantation medicine, pharmacology, and precision oncology into a clinically practical educational platform.

Who Should Take This Course

The UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025 is intended for clinicians involved in cancer diagnosis, treatment, and supportive oncologic care.

This course is especially valuable for:

• Hematologists
• Medical oncologists
• Oncology fellows
• Internal medicine physicians specializing in oncology
• Advanced oncology practitioners
• Hematopoietic transplant specialists
• Oncology pharmacists
• Cancer care clinicians seeking comprehensive oncology updates

The curriculum is particularly relevant for specialists seeking updated expertise in malignant hematology, solid tumor treatment, immunotherapy, transplantation, and supportive cancer medicine.

Clinical Applications & Practice Benefits

The course provides clinically practical education focused on improving oncology treatment planning, supportive care management, and multidisciplinary cancer decision-making.

Participants gain practical insight into:

• Leukemia, lymphoma, and myeloma management
• Contemporary solid tumor treatment algorithms
• Immunotherapy integration into oncology practice
• Precision medicine and targeted therapies
• Cancer-associated thrombosis management
• Supportive care and transfusion strategies
• Hematopoietic cell transplantation approaches
• Oncology pharmacology and adverse effect management
• Evidence-informed oncology treatment planning
• Multidisciplinary cancer care coordination

The educational content strengthens clinical confidence while supporting improved outcomes in patients with hematologic disorders and malignancies.

Professional Summary

The UW Medicine 16th Annual Comprehensive Hematology & Oncology Review Course 2025 from UW Medicine provides a broad and clinically focused review of modern hematology, oncology, immunotherapy, transplantation medicine, and supportive cancer care.

Through 54 expert-led video lectures, downloadable educational resources, and multidisciplinary treatment discussions, the curriculum explores malignant hematology, solid tumor oncology, precision medicine, thrombosis management, supportive care, and evolving therapeutic strategies shaping contemporary cancer care.

Its integration of evidence-informed treatment updates, practical patient management education, and comprehensive oncology review makes this course an essential educational resource for hematologists, oncologists, and clinicians seeking advanced expertise in modern cancer medicine.

4. Topics

• Acute Lymphoblastic Leukemia

• Acute Myeloid Leukemia

• Adjuvant Therapy for Breast Cancer

• Anal Cancer

• Benign White Cell Disorders

• Bladder Cancer

• Bleeding Disorders

• B-NHL, Aggressive Non-Hodgkin Lymphoma

• B-NHL, Indolent Non-Hodgkin Lymphoma

• Cholangiocarcinoma

• Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) & Hairy Cell Leukemia

• Chronic Myeloid Leukemia

• CNS Cancers

• Colorectal Cancer

• Consultative Hematology

• Esophageal-Gastric Cancer

• Familial Syndromes

• Gastrointestinal Neuroendocrine Tumors

• Gynecologic Oncology – Cervical and Endometrial Cancers

• Gynecologic Oncology – Ovarian Cancer

• Head, Neck and Thyroid Cancer

• Hematology Pharmacology Pearls

• Hematopoietic Cell Transplantation

• Hepatocellular Cancer

• Hodgkin Lymphoma

• Infectious Disease Complications

• Inherited & Acquired Marrow Failure

• Integrative Medicine

• Iron Metabolism Disorders & Hemolytic Anemias

• Melanoma and Other Skin Cancers

• Mesothelioma

• Metastatic Breast Cancer

• Myelodysplastic Syndromes

• Myeloproliferative Neoplasms

• Newly-Diagnosed Myeloma

• Non-Small Cell Lung Cancer – Adjuvant-Locally Advanced

• Non-Small Cell Lung Cancer – Metastatic

• Pancreatic Cancer

• Prostate Cancer

• Radiation Oncology – Multi-Disciplinary [Breast, Lung, Colorectal, and Palliative]

• Relapsed-Refractory Myeloma & Amyloidosis

• Renal Cell Carcinoma

• Sarcoma

• Small Cell Lung Cancer

• Smoldering Myeloma & MGUS

• Solid Tumor Pharmacology Pearls

• Supportive Care

• T-Cell Lymphoma – NHL

• Testicular Cancer

• Thalassemia & Hemoglobinopathies

• Therapy for Non-Invasive Breast Cancer

• Thrombocytopenia

• Thrombosis & Anticoagulation

• Transfusion Medicine